Stephen Gange - Publications

Affiliations: 
Johns Hopkins University, Baltimore, MD 
Area:
Public Health, Epidemiology

231 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Althoff KN, Chandran A, Zhang J, Arevalo WM, Gange SJ, Sterling TR, Gill MJ, Justice AC, Palella FJ, Rebeiro PF, Silverberg MJ, Mayor AM, Horberg MA, Thorne JE, Rabkin CS, et al. LIFE EXPECTANCY DISPARITIES AMONG ADULTS WITH HIV IN THE UNITED STATES AND CANADA: THE IMPACT OF A REDUCTION IN DRUG- AND ALCOHOL-RELATED DEATHS USING THE LIVES SAVED SIMULATION (LISSO) MODEL. American Journal of Epidemiology. PMID 31602475 DOI: 10.1093/aje/kwz232  0.48
2019 Althoff KN, Wong C, Hogan B, Desir F, You B, Humes E, Zhang J, Jing Y, Modur S, Lee JS, Freeman A, Kitahata M, Van Rompaey S, Mathews WC, Horberg MA, ... ... Gange SJ, et al. Mind the gap: observation windows to define periods of event ascertainment as a quality control method for longitudinal electronic health record data. Annals of Epidemiology. PMID 31005552 DOI: 10.1016/j.annepidem.2019.01.015  0.48
2019 Althoff KN, Gebo KA, Moore RD, Boyd CM, Justice AC, Wong C, Lucas GM, Klein MB, Kitahata MM, Crane H, Silverberg MJ, Gill MJ, Mathews WC, Dubrow R, Horberg MA, ... ... Gange SJ, et al. Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies. The Lancet. Hiv. PMID 30683625 DOI: 10.1016/S2352-3018(18)30295-9  0.48
2019 Fatukasi TV, Edmonds A, Gustafson DR, Cole SR, Edwards JK, Bolivar H, Cohen M, Fischl MA, Gange S, Konkle-Parker D, Moran CA, Plankey M, Sharma A, Tien PC, Adimora AA. Prevalence and 1-year incidence of frailty among women with and without HIV in the Women's Interagency HIV Study. Aids (London, England). 33: 357-359. PMID 30562174 DOI: 10.1097/QAD.0000000000002047  0.68
2018 Lesko CR, Jacobson LP, Althoff KN, Abraham AG, Gange SJ, Moore RD, Modur S, Lau B. Collaborative, pooled and harmonized study designs for epidemiologic research: challenges and opportunities. International Journal of Epidemiology. PMID 29438495 DOI: 10.1093/ije/dyx283  1
2018 Elion RA, Althoff KN, Zhang J, Moore RD, Gange SJ, Kitahata MM, Crane HM, Drozd DR, Stein JH, Klein MB, Eron JJ, Silverberg MJ, Mathews WC, Justice AC, Sterling TR, et al. Recent abacavir use increases risk for Types 1 and 2 myocardial infarctions among adults with HIV. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29419568 DOI: 10.1097/QAI.0000000000001642  0.48
2017 Wong C, Gange SJ, Moore RD, Justice AC, Buchacz K, Abraham AG, Rebeiro PF, Koethe JR, Martin JN, Horberg MA, Boyd CM, Kitahata MM, Crane HM, Gebo KA, Gill MJ, et al. Multimorbidity Among Persons Living with HIV in the U.S. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29149237 DOI: 10.1093/cid/cix998  0.48
2017 Todd JV, Cole SR, Wohl DA, Simpson RJ, Jonsson Funk M, Brookhart MA, Cocohoba J, Merenstein D, Sharma A, Lazar J, Milam J, Cohen M, Gange S, Lewis TT, Burkholder G, et al. Underutilization of Statins When Indicated in HIV-Seropositive and Seronegative Women. Aids Patient Care and Stds. 31: 447-454. PMID 29087746 DOI: 10.1089/apc.2017.0145  0.68
2017 Lesko CR, Todd JV, Cole SR, Edmonds A, Pence BW, Edwards JK, Mack WJ, Bacchetti P, Rubtsova A, Gange SJ, Adimora AA. Mortality under plausible interventions on antiretroviral treatment and depression in HIV-infected women: an application of the parametric g-formula. Annals of Epidemiology. PMID 28939001 DOI: 10.1016/j.annepidem.2017.08.021  0.68
2017 Drozd DR, Kitahata MM, Althoff KN, Zhang J, Gange SJ, Napravnik S, Burkholder GA, Mathews WC, Silverberg MJ, Sterling TR, Heckbert SR, Budoff MJ, Van Rompaey S, Delaney JAC, Wong C, et al. Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared to the General Population. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28520615 DOI: 10.1097/QAI.0000000000001450  0.48
2017 Todd JV, Cole SR, Pence BW, Lesko CR, Bacchetti P, Cohen MH, Feaster DJ, Gange S, Griswold ME, Mack W, Rubtsova A, Wang C, Weedon J, Anastos K, Adimora AA. Effects of Antiretroviral Therapy and Depressive Symptoms on All-Cause Mortality Among HIV-Infected Women. American Journal of Epidemiology. 1-10. PMID 28430844 DOI: 10.1093/aje/kww192  0.68
2017 Wong C, Gange SJ, Buchacz K, Moore RD, Justice AC, Horberg MA, Gill MJ, Koethe JR, Rebeiro PF, Silverberg MJ, Palella FJ, Patel P, Kitahata MM, Crane HM, Abraham AG, et al. First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000-2013. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 64: 459-467. PMID 28172581 DOI: 10.1093/cid/ciw804  0.48
2016 Wong C, Gange SJ, Buchacz K, Moore RD, Justice AC, Horberg MA, Gill MJ, Koethe JR, Rebeiro PF, Silverberg MJ, Palella FJ, Patel P, Kitahata MM, Crane HM, Abraham AG, et al. First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected adults, 2000-2013. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27940943 DOI: 10.1093/cid/ciw804  0.48
2016 Buchacz K, Lau B, Jing Y, Bosch R, Abraham AG, Gill MJ, Silverberg MJ, Goedert JJ, Sterling TR, Althoff KN, Martin JN, Burkholder G, Gandhi N, Samji H, Patel P, ... ... Gange SJ, et al. Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010. The Journal of Infectious Diseases. 214: 862-72. PMID 27559122 DOI: 10.1093/infdis/jiw085  1
2016 Desai SN, Dodge JL, Landay AL, Glesby MJ, Latham PS, Villacres MC, French AL, Gange SJ, Greenblatt RM, Peters MG. Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study. Medicine. 95: e4483. PMID 27537569 DOI: 10.1097/MD.0000000000004483  1
2016 Rebeiro PF, Gange SJ, Horberg MA, Abraham AG, Napravnik S, Samji H, Yehia BR, Althoff KN, Moore RD, Kitahata MM, Sterling TR, Curriero FC. Geographic Variations in Retention in Care among HIV-Infected Adults in the United States. Plos One. 11: e0146119. PMID 26752637 DOI: 10.1371/journal.pone.0146119  1
2015 Rebeiro PF, Althoff KN, Lau B, Gill J, Abraham AG, Horberg MA, Kitahata MM, Yehia BR, Samji H, Brooks JT, Buchacz K, Napravnik S, Silverberg MJ, Rachlis A, Gebo KA, ... ... Gange SJ, et al. Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America. American Journal of Epidemiology. 182: 952-60. PMID 26578717 DOI: 10.1093/aje/kwv181  1
2015 Gange SJ, Golub ET. From Smallpox to Big Data: The Next 100 Years of Epidemiologic Methods. American Journal of Epidemiology. PMID 26443419 DOI: 10.1093/aje/kwv150  1
2015 Lang Kuhs KA, Kuniholm MH, Pfeiffer RM, Chen S, Desai S, Edlin BR, Peters MG, Plankey M, Sharp GB, Strickler HD, Villacres MC, Quinn TC, Gange SJ, Prokunina-Olsson L, Greenblatt RM, et al. Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes. Plos One. 10: e0138827. PMID 26431156 DOI: 10.1371/journal.pone.0138827  1
2015 Baxi SM, Greenblatt RM, Bacchetti P, Jin C, French AL, Keller MJ, Augenbraun MH, Gange SJ, Liu C, Mack WJ, Gandhi M. Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients. Plos One. 10: e0129100. PMID 26053176 DOI: 10.1371/journal.pone.0129100  1
2015 Hanna DB, Post WS, Deal JA, Hodis HN, Jacobson LP, Mack WJ, Anastos K, Gange SJ, Landay AL, Lazar JM, Palella FJ, Tien PC, Witt MD, Xue X, Young MA, et al. HIV Infection Is Associated With Progression of Subclinical Carotid Atherosclerosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 25904369 DOI: 10.1093/cid/civ325  1
2015 Kitahata MM, Drozd DR, Crane HM, Van Rompaey SE, Althoff KN, Gange SJ, Klein MB, Lucas GM, Abraham AG, Lo Re V, McReynolds J, Lober WB, Mendes A, Modur SP, Jing Y, et al. Ascertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and design. Aids Research and Treatment. 2015: 923194. PMID 25789171 DOI: 10.1155/2015/923194  1
2015 Althoff KN, McGinnis KA, Wyatt CM, Freiberg MS, Gilbert C, Oursler KK, Rimland D, Rodriguez-Barradas MC, Dubrow R, Park LS, Skanderson M, Shiels MS, Gange SJ, Gebo KA, Justice AC, et al. Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 627-38. PMID 25362204 DOI: 10.1093/cid/ciu869  1
2014 Rebeiro PF, Horberg MA, Gange SJ, Gebo KA, Yehia BR, Brooks JT, Buchacz K, Silverberg MJ, Gill J, Moore RD, Althoff KN. Strong agreement of nationally recommended retention measures from the Institute of Medicine and Department of Health and Human Services. Plos One. 9: e111772. PMID 25375099 DOI: 10.1371/journal.pone.0111772  1
2014 Frasco MA, Karim R, Van Den Berg D, Watanabe RM, Anastos K, Cohen M, Gange SJ, Gustafson DR, Liu C, Tien PC, Mack WJ, Pearce CL. Antiretroviral therapy modifies the genetic effect of known type 2 diabetes-associated risk variants in HIV-infected women. Aids (London, England). 28: 1815-23. PMID 24932614 DOI: 10.1097/QAD.0000000000000366  1
2014 Wong C, Althoff K, Gange SJ. Identifying the appropriate comparison group for HIV-infected individuals. Current Opinion in Hiv and Aids. 9: 379-85. PMID 24840058 DOI: 10.1097/COH.0000000000000063  1
2014 Ishwaran H, Gerds TA, Kogalur UB, Moore RD, Gange SJ, Lau BM. Random survival forests for competing risks. Biostatistics (Oxford, England). 15: 757-73. PMID 24728979 DOI: 10.1093/biostatistics/kxu010  0.48
2014 Althoff KN, Rebeiro P, Brooks JT, Buchacz K, Gebo K, Martin J, Hogg R, Thorne JE, Klein M, Gill MJ, Sterling TR, Yehia B, Silverberg MJ, Crane H, Justice AC, ... Gange SJ, et al. Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 1185-9. PMID 24463281 DOI: 10.1093/cid/ciu044  1
2014 Baxi SM, Greenblatt RM, Bacchetti P, Scherzer R, Minkoff H, Huang Y, Anastos K, Cohen M, Gange SJ, Young M, Shlipak MG, Gandhi M. Common clinical conditions - age, low BMI, ritonavir use, mild renal impairment - affect tenofovir pharmacokinetics in a large cohort of HIV-infected women. Aids (London, England). 28: 59-66. PMID 24275255 DOI: 10.1097/QAD.0000000000000033  1
2013 Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, Burchell AN, Cohen M, Gebo KA, Gill MJ, Justice A, Kirk G, Klein MB, Korthuis PT, Martin J, ... ... Gange SJ, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. Plos One. 8: e81355. PMID 24367482 DOI: 10.1371/journal.pone.0081355  1
2013 Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, ... ... Gange SJ, et al. Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009. Plos One. 8: e78952. PMID 24260137 DOI: 10.1371/journal.pone.0078952  1
2013 Estrella MM, Wyatt CM, Pearce CL, Li M, Shlipak MG, Aouizerat BE, Gustafson D, Cohen MH, Gange SJ, Kao WH, Parekh RS. Host APOL1 genotype is independently associated with proteinuria in HIV infection. Kidney International. 84: 834-40. PMID 23715117 DOI: 10.1038/ki.2013.203  1
2013 Kuniholm MH, Anastos K, Kovacs A, Gao X, Marti D, Sette A, Greenblatt RM, Peters M, Cohen MH, Minkoff H, Gange SJ, Thio CL, Young MA, Xue X, Carrington M, et al. Relation of HLA class I and II supertypes with spontaneous clearance of hepatitis C virus. Genes and Immunity. 14: 330-5. PMID 23636221 DOI: 10.1038/gene.2013.25  1
2013 Parrinello CM, Landay AL, Hodis HN, Gange SJ, Norris PJ, Young M, Anastos K, Tien PC, Xue X, Lazar J, Benning L, Tracy RP, Kaplan RC. Treatment-related changes in serum lipids and inflammation: clinical relevance remains unclear. Analyses from the Women's Interagency HIV study. Aids (London, England). 27: 1516-9. PMID 23435295 DOI: 10.1097/QAD.0b013e32835fd8a9  1
2013 Althoff KN, Gange SJ. A critical epidemiological review of cardiovascular disease risk in HIV-infected adults: the importance of the HIV-uninfected comparison group, confounding, and competing risks. Hiv Medicine. 14: 191-2. PMID 23368691 DOI: 10.1111/hiv.12007  1
2013 Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, ... ... Gange SJ, et al. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 56: 1174-82. PMID 23315317 DOI: 10.1093/cid/cit003  1
2013 Estrella MM, Abraham AG, Jing Y, Parekh RS, Tien PC, Merenstein D, Pearce CL, Anastos K, Cohen MH, Dehovitz JA, Gange SJ. Antiretroviral-treated HIV-infected women have similar long-term kidney function trajectories as HIV-uninfected women. Aids Research and Human Retroviruses. 29: 755-60. PMID 23273313 DOI: 10.1089/AID.2012.0248  1
2013 Abraham AG, D'Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, Saag MS, Rourke SB, Rachlis A, Napravnik S, Moore RD, Klein MB, Kitahata MM, Kirk GD, Hogg RS, et al. Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. Journal of Acquired Immune Deficiency Syndromes (1999). 62: 405-13. PMID 23254153 DOI: 10.1097/QAI.0b013e31828177d7  1
2013 Rebeiro P, Althoff KN, Buchacz K, Gill J, Horberg M, Krentz H, Moore R, Sterling TR, Brooks JT, Gebo KA, Hogg R, Klein M, Martin J, Mugavero M, Rourke S, ... ... Gange SJ, et al. Retention among North American HIV-infected persons in clinical care, 2000-2008. Journal of Acquired Immune Deficiency Syndromes (1999). 62: 356-62. PMID 23242158 DOI: 10.1097/QAI.0b013e31827f578a  1
2013 Justice AC, Modur SP, Tate JP, Althoff KN, Jacobson LP, Gebo KA, Kitahata MM, Horberg MA, Brooks JT, Buchacz K, Rourke SB, Rachlis A, Napravnik S, Eron J, Willig JH, ... ... Gange SJ, et al. Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. Journal of Acquired Immune Deficiency Syndromes (1999). 62: 149-63. PMID 23187941 DOI: 10.1097/QAI.0b013e31827df36c  1
2012 Parrinello CM, Landay AL, Hodis HN, Gange SJ, Norris PJ, Young M, Anastos K, Tien PC, Xue X, Lazar J, Benning L, Tracy RP, Kaplan RC. Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women's Interagency HIV study. Atherosclerosis. 225: 408-11. PMID 23089369 DOI: 10.1016/j.atherosclerosis.2012.09.035  1
2012 Althoff KN, Buchacz K, Hall HI, Zhang J, Hanna DB, Rebeiro P, Gange SJ, Moore RD, Kitahata MM, Gebo KA, Martin J, Justice AC, Horberg MA, Hogg RS, Sterling TR, et al. U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Annals of Internal Medicine. 157: 325-35. PMID 22944874 DOI: 10.7326/0003-4819-157-5-201209040-00005  1
2012 Gandhi M, Greenblatt RM, Bacchetti P, Jin C, Huang Y, Anastos K, Cohen M, Dehovitz JA, Sharp GB, Gange SJ, Liu C, Hanson SC, Aouizerat B. A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women. The Journal of Infectious Diseases. 206: 1453-61. PMID 22927450 DOI: 10.1093/infdis/jis508  1
2012 Xie X, Xue X, Gange SJ, Strickler HD, Kim MY. Estimation and inference on correlations between biomarkers with repeated measures and left-censoring due to minimum detection levels. Statistics in Medicine. 31: 2275-89. PMID 22714546 DOI: 10.1002/sim.5371  1
2012 Villacres MC, Kono N, Mack WJ, Nowicki MJ, Anastos K, Augenbraun M, Liu C, Landay A, Greenblatt RM, Gange SJ, Levine AM. Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection. The Journal of Infectious Diseases. 206: 780-9. PMID 22693231 DOI: 10.1093/infdis/jis380  1
2012 Sarkar M, Bacchetti P, French AL, Tien P, Glesby MJ, Nowicki M, Plankey M, Gange S, Sharp G, Minkoff H, Peters MG. Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women. Hepatology (Baltimore, Md.). 56: 1699-705. PMID 22618868 DOI: 10.1002/hep.25859  1
2012 Kaplan RC, Landay AL, Hodis HN, Gange SJ, Norris PJ, Young M, Anastos K, Tien PC, Xue X, Lazar J, Parrinello CM, Benning L, Tracy RP. Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment. Journal of Acquired Immune Deficiency Syndromes (1999). 60: 359-68. PMID 22592585 DOI: 10.1097/QAI.0b013e31825b03be  1
2012 Westreich D, Cole SR, Young JG, Palella F, Tien PC, Kingsley L, Gange SJ, Hernán MA. The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. Statistics in Medicine. 31: 2000-9. PMID 22495733 DOI: 10.1002/sim.5316  1
2012 Parrinello CM, Sinclair E, Landay AL, Lurain N, Sharrett AR, Gange SJ, Xue X, Hunt PW, Deeks SG, Hodis HN, Kaplan RC. Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. The Journal of Infectious Diseases. 205: 1788-96. PMID 22492856 DOI: 10.1093/infdis/jis276  1
2012 Bambha K, Pierce C, Cox C, French AL, Tien PC, Sharp GB, Augenbraun M, Glesby MJ, Villacres MC, Plankey M, Strickler HD, Gange SJ, Peters MG. Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis. Aids (London, England). 26: 599-607. PMID 22156972 DOI: 10.1097/QAD.0b013e32834fa121  1
2012 Hanna DB, Selik RM, Tang T, Gange SJ. Disparities among US states in HIV-related mortality in persons with HIV infection, 2001-2007. Aids (London, England). 26: 95-103. PMID 22008659 DOI: 10.1097/QAD.0b013e32834dcf87  1
2012 Lau B, Gange S, Cole SR. Clarification and correction Statistics in Medicine. 31: 1777-1778. DOI: 10.1002/sim.4468  1
2011 Kuniholm MH, Gao X, Xue X, Kovacs A, Anastos K, Marti D, Greenblatt RM, Cohen MH, Minkoff H, Gange SJ, Fazzari M, Young MA, Strickler HD, Carrington M. Human leukocyte antigen genotype and risk of HIV disease progression before and after initiation of antiretroviral therapy. Journal of Virology. 85: 10826-33. PMID 21849458 DOI: 10.1128/JVI.00804-11  1
2011 Sterling TR, Lau B, Zhang J, Freeman A, Bosch RJ, Brooks JT, Deeks SG, French A, Gange S, Gebo KA, John Gill M, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, et al. Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. The Journal of Infectious Diseases. 204: 893-901. PMID 21849286 DOI: 10.1093/infdis/jir421  1
2011 Abraham AG, Lau B, Deeks S, Moore RD, Zhang J, Eron J, Harrigan R, Gill MJ, Kitahata M, Klein M, Napravnik S, Rachlis A, Rodriguez B, Rourke S, Benson C, ... ... Gange SJ, et al. Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america. American Journal of Epidemiology. 174: 727-35. PMID 21813792 DOI: 10.1093/aje/kwr141  1
2011 Berry SA, Ghanem KG, Page KR, Gange SJ, Thio CL, Moore RD, Gebo KA. Increased gonorrhoea and chlamydia testing did not increase case detection in an HIV clinical cohort 1999-2007. Sexually Transmitted Infections. 87: 469-75. PMID 21745834 DOI: 10.1136/sextrans-2011-050051  1
2011 Kuniholm MH, Gao X, Xue X, Kovacs A, Marti D, Thio CL, Peters MG, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Young MA, et al. The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women. The Journal of Infectious Diseases. 203: 1807-14. PMID 21606539 DOI: 10.1093/infdis/jir192  1
2011 Genberg BL, Gange SJ, Go VF, Celentano DD, Kirk GD, Latkin CA, Mehta SH. The effect of neighborhood deprivation and residential relocation on long-term injection cessation among injection drug users (IDUs) in Baltimore, Maryland. Addiction (Abingdon, England). 106: 1966-74. PMID 21592251 DOI: 10.1111/j.1360-0443.2011.03501.x  1
2011 Keating SM, Golub ET, Nowicki M, Young M, Anastos K, Crystal H, Cohen MH, Zhang J, Greenblatt RM, Desai S, Wu S, Landay AL, Gange SJ, Norris PJ. The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women. Aids (London, England). 25: 1823-32. PMID 21572306 DOI: 10.1097/QAD.0b013e3283489d1f  1
2011 Aumakhan B, Gange SJ, Beyrer C, Gaydos CA, Minkoff H, Merenstein DJ, Cohen MH, Anastos K, Greenblatt R, Nowicki MJ, Quinn TC. Quantitative and qualitative correlates of cervicovaginal herpes simplex virus type 2 shedding among HIV-infected women in the Women's Interagency HIV Study. International Journal of Std & Aids. 22: 273-7. PMID 21571975 DOI: 10.1258/ijsa.2009.009296  1
2011 Gandhi M, Ameli N, Bacchetti P, Anastos K, Gange SJ, Minkoff H, Young M, Milam J, Cohen MH, Sharp GB, Huang Y, Greenblatt RM. Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 1267-75. PMID 21507924 DOI: 10.1093/cid/cir131  1
2011 Althoff KN, Eichelberger M, Gange SJ, Sharp GB, Gao J, Glesby MJ, Young M, Greenblatt RM, French AL, Villacres MC, Minkoff H. Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability. Aids (London, England). 25: 1229-32. PMID 21505313 DOI: 10.1097/QAD.0b013e3283471cf2  1
2011 Kaplan RC, Sinclair E, Landay AL, Lurain N, Sharrett AR, Gange SJ, Xue X, Parrinello CM, Hunt P, Deeks SG, Hodis HN. T cell activation predicts carotid artery stiffness among HIV-infected women. Atherosclerosis. 217: 207-13. PMID 21492857 DOI: 10.1016/j.atherosclerosis.2011.03.011  1
2011 Nowak RG, Gravitt PE, Morrison CS, Gange SJ, Kwok C, Oliver AE, Howard R, Van Der Pol B, Salata RA, Padian NS, Chipato T, Munjoma M, Celentano DD. Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe Journal of Infectious Diseases. 203: 1182-1191. PMID 21451006 DOI: 10.1093/infdis/jiq172  1
2011 Huang YF, Kuo HS, Lew-Ting CY, Tian F, Yang CH, Tsai TI, Gange SJ, Nelson KE. Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan. Addiction (Abingdon, England). 106: 1437-45. PMID 21438941 DOI: 10.1111/j.1360-0443.2011.03443.x  1
2011 Lau B, Cole SR, Gange SJ. Parametric mixture models to evaluate and summarize hazard ratios in the presence of competing risks with time-dependent hazards and delayed entry. Statistics in Medicine. 30: 654-65. PMID 21337360 DOI: 10.1002/sim.4123  1
2011 Genberg BL, Gange SJ, Go VF, Celentano DD, Kirk GD, Mehta SH. Trajectories of injection drug use over 20 years (1988-2008) in Baltimore, Maryland. American Journal of Epidemiology. 173: 829-36. PMID 21320867 DOI: 10.1093/aje/kwq441  1
2011 Kaplan RC, Sinclair E, Landay AL, Lurain N, Sharrett AR, Gange SJ, Xue X, Hunt P, Karim R, Kern DM, Hodis HN, Deeks SG. T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. The Journal of Infectious Diseases. 203: 452-63. PMID 21220772 DOI: 10.1093/infdis/jiq071  1
2010 Althoff KN, Gebo KA, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Eron JJ, Napravnik S, Rourke SB, Gill MJ, Rodriguez B, et al. CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation? Aids Research and Therapy. 7: 45. PMID 21159161 DOI: 10.1186/1742-6405-7-45  1
2010 Aumakhan B, Hardick A, Quinn TC, Laeyendecker O, Gange SJ, Beyrer C, Cox C, Anastos K, Cohen M, Greenblatt RM, Merenstein DJ, Minkoff H, Nowicki M, Gaydos CA. Genital herpes evaluation by quantitative TaqMan PCR: correlating single detection and quantity of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and longitudinal clinical data. Virology Journal. 7: 328. PMID 21087488 DOI: 10.1186/1743-422X-7-328  1
2010 Abraham AG, Gange SJ, Rawleigh SB, Glass LR, Springer G, Samet JM. Retrospective mortality study among employees occupationally exposed to toner. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 52: 1035-41. PMID 20881618 DOI: 10.1097/JOM.0b013e3181f73afc  1
2010 Althoff KN, Justice AC, Gange SJ, Deeks SG, Saag MS, Silverberg MJ, Gill MJ, Lau B, Napravnik S, Tedaldi E, Klein MB, Gebo KA. Virologic and immunologic response to HAART, by age and regimen class. Aids (London, England). 24: 2469-79. PMID 20829678 DOI: 10.1097/QAD.0b013e32833e6d14  1
2010 Lau B, Chander G, Gange SJ, Moore RD. Identifying individuals with virologic failure after initiating effective antiretroviral therapy: The surprising value of mean corpuscular hemoglobin in a cross-sectional study. Aids Research and Therapy. 7: 25. PMID 20653950 DOI: 10.1186/1742-6405-7-25  1
2010 Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, Obel N, Castagna A, Wasmuth JC, Gill J, ... ... Gange S, et al. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study. Lancet. 376: 340-5. PMID 20638118 DOI: 10.1016/S0140-6736(10)60932-4  1
2010 Palella FJ, Gange SJ, Benning L, Jacobson L, Kaplan RC, Landay AL, Tracy RP, Elion R. Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study. Aids (London, England). 24: 1657-65. PMID 20588104 DOI: 10.1097/QAD.0b013e3283389dfa  1
2010 Estrella MM, Parekh RS, Abraham A, Astor BC, Szczech LA, Anastos K, Dehovitz JA, Merenstein DJ, Pearce CL, Tien PC, Cohen MH, Gange SJ. The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women. Journal of Acquired Immune Deficiency Syndromes (1999). 55: 217-20. PMID 20581688 DOI: 10.1097/QAI.0b013e3181e674f4  1
2010 Ronquillo RE, Desai SN, Norris PJ, Golub ET, Greenblatt RM, Gange SJ, Landay AL. Elevated caspase-3 expression and T-cell activation in elite suppressors. Journal of Acquired Immune Deficiency Syndromes (1999). 54: 110-1. PMID 20418727 DOI: 10.1097/QAI.0b013e3181cbd469  1
2010 Althoff KN, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Justice AC, Gebo KA, Eron JJ, Rourke SB, Gill MJ, Rodriguez B, et al. Late presentation for human immunodeficiency virus care in the United States and Canada. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 50: 1512-20. PMID 20415573 DOI: 10.1086/652650  1
2010 Chu H, Gange SJ, Li X, Hoover DR, Liu C, Chmiel JS, Jacobson LP. The effect of HAART on HIV RNA trajectory among treatment-naïve men and women: a segmental Bernoulli/lognormal random effects model with left censoring. Epidemiology (Cambridge, Mass.). 21: S25-34. PMID 20386106 DOI: 10.1097/EDE.0b013e3181ce9950  1
2010 Aumakhan B, Gaydos CA, Quinn TC, Beyrer C, Benning L, Minkoff H, Merenstein DJ, Cohen M, Greenblatt R, Nowicki M, Anastos K, Gange SJ. Clinical reactivations of herpes simplex virus type 2 infection and human immunodeficiency virus disease progression markers. Plos One. 5: e9973. PMID 20376310 DOI: 10.1371/journal.pone.0009973  1
2010 Althoff KN, Anastos K, Nelson KE, Celentano DD, Sharp GB, Greenblatt RM, French AL, Diamond DJ, Holman S, Young M, Gange SJ. Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006-2007 and 2007-2008 seasons. Preventive Medicine. 50: 223-9. PMID 20303362 DOI: 10.1016/j.ypmed.2010.03.007  1
2010 Kuniholm MH, Kovacs A, Gao X, Xue X, Marti D, Thio CL, Peters MG, Terrault NA, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, et al. Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology (Baltimore, Md.). 51: 1514-22. PMID 20169624 DOI: 10.1002/hep.23515  1
2010 McMahon D, Jones J, Wiegand A, Gange SJ, Kearney M, Palmer S, McNulty S, Metcalf JA, Acosta E, Rehm C, Coffin JM, Mellors JW, Maldarelli F. Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 50: 912-9. PMID 20156060 DOI: 10.1086/650749  1
2010 Xue X, Gange SJ, Zhong Y, Burk RD, Minkoff H, Massad LS, Watts DH, Kuniholm MH, Anastos K, Levine AM, Fazzari M, D'Souza G, Plankey M, Palefsky JM, Strickler HD. Marginal and mixed-effects models in the analysis of human papillomavirus natural history data. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 159-69. PMID 20056635 DOI: 10.1158/1055-9965.EPI-09-0546  1
2010 Galárraga O, Salkever DS, Cook JA, Gange SJ. An instrumental variables evaluation of the effect of antidepressant use on employment among HIV-infected women using antiretroviral therapy in the United States: 1996-2004. Health Economics. 19: 173-88. PMID 19253267 DOI: 10.1002/hec.1458  1
2009 Terzian AS, Holman S, Nathwani N, Robison E, Weber K, Young M, Greenblatt RM, Gange SJ. Factors associated with preclinical disability and frailty among HIV-infected and HIV-uninfected women in the era of cART. Journal of Women's Health (2002). 18: 1965-74. PMID 20044858 DOI: 10.1089/jwh.2008.1090  1
2009 Abraham AG, Duncan DD, Gange SJ, West S. Computer-aided assessment of diagnostic images for epidemiological research. Bmc Medical Research Methodology. 9: 74. PMID 19906311 DOI: 10.1186/1471-2288-9-74  1
2009 Deeks SG, Gange SJ, Kitahata MM, Saag MS, Justice AC, Hogg RS, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Benson CA, Collier AC, Martin JN, Klein MB, et al. Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 1582-90. PMID 19845473 DOI: 10.1086/644768  1
2009 Liu C, Yang Y, Gange SJ, Weber K, Sharp GB, Wilson TE, Levine A, Robison E, Goparaju L, Gandhi M, Ganhdi M, Merenstein D. Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women. Aids Patient Care and Stds. 23: 965-71. PMID 19821723 DOI: 10.1089/apc.2009.0134  1
2009 Mansoor A, Althoff K, Gange S, Anastos K, Dehovitz J, Minkoff H, Kaplan R, Holman S, Lazar JM. Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women. Aids Research and Human Retroviruses. 25: 997-1004. PMID 19803714 DOI: 10.1089/aid.2009.0038  1
2009 Cheskin LJ, Gange SJ. BMI <22.5 and >25 predicted higher overall mortality in adults. Evidence-Based Medicine. 14: 152. PMID 19794027 DOI: 10.1136/ebm.14.5.152  1
2009 Sethi AK, Gange SJ. Parametric models for studying time to antiretroviral resistance associated with illicit drug use. Wmj : Official Publication of the State Medical Society of Wisconsin. 108: 266-8. PMID 19743761  1
2009 Ganesan A, Benning L, Golub ET, Riddle M, Crum-Cianflone N, Tasker S, Jacobson L, Gange SJ. Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens. Aids Research and Therapy. 6: 13. PMID 19545433 DOI: 10.1186/1742-6405-6-13  1
2009 Feldman DN, Feldman JG, Greenblatt R, Anastos K, Pearce L, Cohen M, Gange S, Leanza S, Burk R. CYP1A1 genotype modifies the impact of smoking on effectiveness of HAART among women. Aids Education and Prevention : Official Publication of the International Society For Aids Education. 21: 81-93. PMID 19537956 DOI: 10.1521/aeap.2009.21.3_supp.81  1
2009 Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. American Journal of Epidemiology. 170: 244-56. PMID 19494242 DOI: 10.1093/aje/kwp107  1
2009 Templeton AR, Kramer MG, Jarvis J, Kowalski J, Gange S, Schneider MF, Shao Q, Zhang GW, Yeh MF, Tsai HL, Zhang H, Markham RB. Multiple-infection and recombination in HIV-1 within a longitudinal cohort of women. Retrovirology. 6: 54. PMID 19493346 DOI: 10.1186/1742-4690-6-54  1
2009 Lau B, Gange SJ, Kirk GD, Moore RD. Evaluation of human immunodeficiency virus biomarkers: inferences from interval and clinical cohort studies. Epidemiology (Cambridge, Mass.). 20: 664-72. PMID 19478669 DOI: 10.1097/EDE.0b013e3181a71519  1
2009 Gandhi M, Benet LZ, Bacchetti P, Kalinowski A, Anastos K, Wolfe AR, Young M, Cohen M, Minkoff H, Gange SJ, Greenblatt RM. Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women. Journal of Acquired Immune Deficiency Syndromes (1999). 50: 482-91. PMID 19408353 DOI: 10.1097/QAI.0b013e31819c3376  1
2009 Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. The New England Journal of Medicine. 360: 1815-26. PMID 19339714 DOI: 10.1056/NEJMoa0807252  1
2009 Silverberg MJ, Jacobson LP, French AL, Witt MD, Gange SJ. Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy. Journal of Pain and Symptom Management. 38: 197-207. PMID 19329274 DOI: 10.1016/j.jpainsymman.2008.08.007  1
2009 Kowalski J, Gange SJ, Schneider MF, Tsai HL, Templeton A, Shao Q, Zhang GW, Yeh MF, Young M, Markham RB. Relationship of injection drug use, antiretroviral therapy resistance, and genetic diversity in the HIV-1 pol gene. Journal of Acquired Immune Deficiency Syndromes (1999). 50: 381-9. PMID 19214121 DOI: 10.1097/QAI.0b013e318198a619  1
2009 Phelan DF, Gange SJ, Ahdieh-Grant L, Mehta SH, Kirk GD, Shah K, Gravitt P. Determinants of newly detected human papillomavirus infection in HIV-infected and HIV-uninfected injection drug using women. Sexually Transmitted Diseases. 36: 149-56. PMID 19174735 DOI: 10.1097/OLQ.0b013e31818d3df3  1
2009 Gandhi M, Ameli N, Bacchetti P, Gange SJ, Anastos K, Levine A, Hyman CL, Cohen M, Young M, Huang Y, Greenblatt RM. Protease inhibitor levels in hair strongly predict virologic response to treatment. Aids (London, England). 23: 471-8. PMID 19165084 DOI: 10.1097/QAD.0b013e328325a4a9  1
2009 Kitahata MM, Gange SJ, Moore RD. The authors reply New England Journal of Medicine. 361: 823-824.  1
2008 Egner PA, Kensler TW, Chen JG, Gange SJ, Groopman JD, Friesen MD. Quantification of sulforaphane mercapturic acid pathway conjugates in human urine by high-performance liquid chromatography and isotope-dilution tandem mass spectrometry. Chemical Research in Toxicology. 21: 1991-6. PMID 18729326 DOI: 10.1021/tx800210k  1
2008 Kaplan RC, Kingsley LA, Gange SJ, Benning L, Jacobson LP, Lazar J, Anastos K, Tien PC, Sharrett AR, Hodis HN. Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. Aids (London, England). 22: 1615-24. PMID 18670221 DOI: 10.1097/QAD.0b013e328300581d  1
2008 Safaeian M, Kiddugavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, Gray R. Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1300-7. PMID 18559545 DOI: 10.1158/1055-9965.EPI-07-2678  1
2008 Lau B, Cole SR, Moore RD, Gange SJ. Evaluating competing adverse and beneficial outcomes using a mixture model. Statistics in Medicine. 27: 4313-27. PMID 18416435 DOI: 10.1002/sim.3293  1
2008 Safaeian M, Kiddugavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, Gray R. Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda. Sexually Transmitted Infections. 84: 306-11. PMID 18385223 DOI: 10.1136/sti.2007.027318  1
2008 Strickler HD, Howard AA, Peters M, Fazzari M, Yu H, Augenbraun M, French AL, Young M, Gange S, Anastos K, Kovacs A. The insulin-like growth factor axis and risk of liver disease in hepatitis C virus/HIV-co-infected women. Aids (London, England). 22: 527-31. PMID 18301066 DOI: 10.1097/QAD.0b013e3282f22cdf  1
2008 Gange SJ. Teaching epidemiologic methods. Epidemiology (Cambridge, Mass.). 19: 353-6. PMID 18277171 DOI: 10.1097/EDE.0b013e318163d294  1
2008 Harris TG, Burk RD, Yu H, Minkoff H, Massad LS, Watts DH, Zhong Y, Gange S, Kaplan RC, Anastos K, Levine AM, Moxley M, Xue X, Fazzari M, Palefsky JM, et al. Insulin-like growth factor axis and oncogenic human papillomavirus natural history. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 245-8. PMID 18199731 DOI: 10.1158/1055-9965.EPI-07-0686  1
2008 Strickler HD, Fazzari M, Kovacs A, Isasi C, Napolitano LA, Minkoff H, Gange S, Young M, Sharp GB, Kaplan RC, Cohen M, Gunter MJ, Harris TG, Yu H, Schoenbaum E, et al. Associations of insulin-like growth factor (IGF)-I and IGF-binding protein-3 with HIV disease progression in women. The Journal of Infectious Diseases. 197: 319-27. PMID 18177247 DOI: 10.1086/524848  1
2008 Cocohoba J, Wang QJ, Cox C, Gange SJ, Cohen M, Glesby M, DeHovitz JA, Greenblatt RM. Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women. Journal of Acquired Immune Deficiency Syndromes (1999). 47: 377-83. PMID 18176324 DOI: 10.1097/QAI.0b013e318160d552  1
2008 Golub ET, Benning L, Sharma A, Gandhi M, Cohen MH, Young M, Gange SJ. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: 305-12. PMID 18171267 DOI: 10.1086/524752  1
2007 Lazo M, Gange SJ, Wilson TE, Anastos K, Ostrow DG, Witt MD, Jacobson LP. Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45: 1377-85. PMID 17968839 DOI: 10.1086/522762  1
2007 Kaplan RC, Kingsley LA, Sharrett AR, Li X, Lazar J, Tien PC, Mack WJ, Cohen MH, Jacobson L, Gange SJ. Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45: 1074-81. PMID 17879928 DOI: 10.1086/521935  1
2007 Harris TG, Burk RD, Xue X, Anastos K, Minkoff H, Massad LS, Young MA, Levine AM, Gange SJ, Watts DH, Palefsky JM, Strickler HD. Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women. Aids (London, England). 21: 1933-41. PMID 17721101 DOI: 10.1097/QAD.0b013e3282c3a945  1
2007 Lau B, Gange SJ, Moore RD. Interval and clinical cohort studies: epidemiological issues. Aids Research and Human Retroviruses. 23: 769-76. PMID 17604539 DOI: 10.1089/aid.2006.0171  1
2007 Morris JD, Golub ET, Mehta SH, Jacobson LP, Gange SJ. Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts. Aids Research and Therapy. 4: 12. PMID 17553140 DOI: 10.1186/1742-6405-4-12  1
2007 Nowicki MJ, Karim R, Mack WJ, Minkoff H, Anastos K, Cohen M, Greenblatt RM, Young MA, Gange SJ, Levine AM. Correlates of CD4+ and CD8+ lymphocyte counts in high-risk immunodeficiency virus (HIV)-seronegative women enrolled in the women's interagency HIV study (WIHS). Human Immunology. 68: 342-9. PMID 17462501 DOI: 10.1016/j.humimm.2007.01.007  1
2007 Massad LS, Fazzari MJ, Anastos K, Klein RS, Minkoff H, Jamieson DJ, Duerr A, Celentano D, Gange S, Cu-Uvin S, Young M, Watts DH, Levine AM, Schuman P, Harris TG, et al. Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV. Journal of Lower Genital Tract Disease. 11: 90-7. PMID 17415113 DOI: 10.1097/01.lgt.0000245038.06977.a7  1
2007 Wilson TE, Feldman J, Vega MY, Gandhi M, Richardson J, Cohen MH, McKaig R, Ostrow D, Robison E, Gange SJ. Acquisition of new sexual partners among women with HIV infection: patterns of disclosure and sexual behavior within new partnerships. Aids Education and Prevention : Official Publication of the International Society For Aids Education. 19: 151-9. PMID 17411417 DOI: 10.1521/aeap.2007.19.2.151  1
2007 Persaud D, Ray SC, Kajdas J, Ahonkhai A, Siberry GK, Ferguson K, Ziemniak C, Quinn TC, Casazza JP, Zeichner S, Gange SJ, Watson DC. Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy. Aids Research and Human Retroviruses. 23: 381-90. PMID 17411371 DOI: 10.1089/aid.2006.0175  1
2007 Siliciano JD, Lai J, Callender M, Pitt E, Zhang H, Margolick JB, Gallant JE, Cofrancesco J, Moore RD, Gange SJ, Siliciano RF. Stability of the latent reservoir for HIV-1 in patients receiving valproic acid. The Journal of Infectious Diseases. 195: 833-6. PMID 17299713 DOI: 10.1086/511823  1
2007 Gange SJ, Kitahata MM, Saag MS, Bangsberg DR, Bosch RJ, Brooks JT, Calzavara L, Deeks SG, Eron JJ, Gebo KA, Gill MJ, Haas DW, Hogg RS, Horberg MA, Jacobson LP, et al. Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). International Journal of Epidemiology. 36: 294-301. PMID 17213214 DOI: 10.1093/ije/dyl286  0.48
2007 Lau B, Gange SJ, Moore RD. Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3. Journal of Acquired Immune Deficiency Syndromes (1999). 44: 179-87. PMID 17075385 DOI: 10.1097/01.qai.0000247229.68246.c5  1
2006 Nguyen RH, Gange SJ, Wabwire-Mangen F, Sewankambo NK, Serwadda D, Wawer MJ, Quinn TC, Gray RH. Reduced fertility among HIV-infected women associated with viral load in Rakai district, Uganda. International Journal of Std & Aids. 17: 842-6. PMID 17212863 DOI: 10.1258/095646206779307586  1
2006 Cole SR, Chu H, Allison PD, Gange SJ. Combined analysis of retrospective and prospective occurrences in cohort studies: HIV-1 serostatus and incident pneumonia. International Journal of Epidemiology. 35: 1442-6. PMID 16936292 DOI: 10.1093/ije/dyl176  1
2006 Margolick JB, Gange SJ, Detels R, O'Gorman MR, Rinaldo CR, Lai S. Impact of inversion of the CD4/CD8 ratio on the natural history of HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes (1999). 42: 620-6. PMID 16868499 DOI: 10.1097/01.qai.0000223028.55080.9d  1
2006 Silverberg MJ, Wegner SA, Milazzo MJ, McKaig RG, Williams CF, Agan BK, Armstrong AW, Gange SJ, Hawkes C, O'Connell RJ, Ahuja SK, Dolan MJ. Effectiveness of highly-active antiretroviral therapy by race/ethnicity. Aids (London, England). 20: 1531-8. PMID 16847408 DOI: 10.1097/01.aids.0000237369.41617.0f  1
2006 Chattopadhyay PK, Douek DC, Gange SJ, Chadwick KR, Hellerstein M, Margolick JB. Longitudinal assessment of de novo T cell production in relation to HIV-associated T cell homeostasis failure. Aids Research and Human Retroviruses. 22: 501-7. PMID 16796525 DOI: 10.1089/aid.2006.22.501  1
2006 Freeman EE, Gange SJ, Muñoz B, West SK. Driving status and risk of entry into long-term care in older adults. American Journal of Public Health. 96: 1254-9. PMID 16735633 DOI: 10.2105/AJPH.2005.069146  1
2006 Burke-Miller JK, Cook JA, Cohen MH, Hessol NA, Wilson TE, Richardson JL, Williams P, Gange SJ. Longitudinal relationships between use of highly active antiretroviral therapy and satisfaction with care among women living with HIV/AIDS. American Journal of Public Health. 96: 1044-51. PMID 16670232 DOI: 10.2105/AJPH.2005.061929  1
2006 Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, Gandhi M, Mocharnuk RS, Anastos K. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. American Journal of Public Health. 96: 1060-5. PMID 16670229 DOI: 10.2105/AJPH.2005.062745  1
2006 Ameli N, Bacchetti P, Morrow RA, Hessol NA, Wilkin T, Young M, Cohen M, Minkoff H, Gange SJ, Greenblatt RM. Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations. Aids (London, England). 20: 1051-8. PMID 16603858 DOI: 10.1097/01.aids.0000222078.75867.77  1
2006 Liu C, Weber K, Robison E, Hu Z, Jacobson LP, Gange SJ. Assessing the effect of HAART on change in quality of life among HIV-infected women. Aids Research and Therapy. 3: 6. PMID 16549012 DOI: 10.1186/1742-6405-3-6  1
2006 Levine AM, Karim R, Mack W, Gravink DJ, Anastos K, Young M, Cohen M, Newman M, Augenbraun M, Gange S, Watts DH. Neutropenia in human immunodeficiency virus infection: data from the women's interagency HIV study. Archives of Internal Medicine. 166: 405-10. PMID 16505259 DOI: 10.1001/archinte.166.4.405  1
2006 Golub J, Bur S, Cronin WA, Gange S, Baruch N, Comstock GW, Chaisson RE. Delayed tuberculosis diagnosis and tuberculosis transmission International Journal of Tuberculosis and Lung Disease. 10: 24-30. PMID 16466033  1
2006 Nguyen RH, Gange SJ, Serwadda D, Kigozi G, Kiwanuka N, Sewankambo NK, Wabwire-Mangen F, Quinn TC, Wawer M, Gray RH. Screening HIV-positive pregnant women for antiretroviral therapy: utility of self-reported symptoms. International Journal of Std & Aids. 17: 112-5. PMID 16464273 DOI: 10.1258/095646206775455801  1
2006 Lau B, Sharrett AR, Kingsley LA, Post W, Palella FJ, Visscher B, Gange SJ. C-reactive protein is a marker for human immunodeficiency virus disease progression. Archives of Internal Medicine. 166: 64-70. PMID 16401812 DOI: 10.1001/archinte.166.1.64  1
2006 Gange SJ, Schneider MF, Grant RM, Liegler T, French A, Young M, Anastos K, Wilson TE, Ponath C, Greenblatt R. Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure. Journal of Acquired Immune Deficiency Syndromes (1999). 41: 68-74. PMID 16340476 DOI: 10.1097/01.qai.0000174652.40782.4e  1
2005 Kensler TW, Chen JG, Egner PA, Fahey JW, Jacobson LP, Stephenson KK, Ye L, Coady JL, Wang JB, Wu Y, Sun Y, Zhang QN, Zhang BC, Zhu YR, Qian GS, ... ... Gange SJ, et al. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 2605-13. PMID 16284385 DOI: 10.1158/1055-9965.EPI-05-0368  1
2005 Schneider MF, Gange SJ, Williams CM, Anastos K, Greenblatt RM, Kingsley L, Detels R, Muñoz A. Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004. Aids (London, England). 19: 2009-18. PMID 16260908  1
2005 Gandhi M, Ameli N, Bacchetti P, Sharp GB, French AL, Young M, Gange SJ, Anastos K, Holman S, Levine A, Greenblatt RM. Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols. Aids (London, England). 19: 1885-96. PMID 16227797  1
2005 Schlecht NF, Burk RD, Palefsky JM, Minkoff H, Xue X, Massad LS, Bacon M, Levine AM, Anastos K, Gange SJ, Watts DH, Da Costa MM, Chen Z, Bang JY, Fazzari M, et al. Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women. The Journal of General Virology. 86: 2709-20. PMID 16186224 DOI: 10.1099/vir.0.81060-0  1
2005 Golub JE, Bur S, Cronin WA, Gange S, Baruch N, Comstock GW, Chaisson RE. Patient and health care system delays in pulmonary tuberculosis diagnosis in a low-incidence state International Journal of Tuberculosis and Lung Disease. 9: 992-998. PMID 16158891  1
2005 Bacon MC, von Wyl V, Alden C, Sharp G, Robison E, Hessol N, Gange S, Barranday Y, Holman S, Weber K, Young MA. The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clinical and Diagnostic Laboratory Immunology. 12: 1013-9. PMID 16148165 DOI: 10.1128/CDLI.12.9.1013-1019.2005  1
2005 Massad LS, Evans CT, Strickler HD, Burk RD, Watts DH, Cashin L, Darragh T, Gange S, Lee YC, Moxley M, Levine A, Passaro DJ. Outcome after negative colposcopy among human immunodeficiency virus-infected women with borderline cytologic abnormalities. Obstetrics and Gynecology. 106: 525-32. PMID 16135582 DOI: 10.1097/01.AOG.0000172429.45130.1f  1
2005 Chu H, Gange SJ, Yamashita TE, Hoover DR, Chmiel JS, Margolick JB, Jacobson LP. Individual variation in CD4 cell count trajectory among human immunodeficiency virus-infected men and women on long-term highly active antiretroviral therapy: an application using a Bayesian random change-point model. American Journal of Epidemiology. 162: 787-97. PMID 16135508 DOI: 10.1093/aje/kwi268  1
2005 Lau B, Gange SJ, Phair JP, Riddler SA, Detels R, Margolick JB. Use of total lymphocyte count and hemoglobin concentration for monitoring progression of HIV infection. Journal of Acquired Immune Deficiency Syndromes (1999). 39: 620-5. PMID 16044017  1
2005 Anastos K, Schneider MF, Gange SJ, Minkoff H, Greenblatt RM, Feldman J, Levine A, Delapenha R, Cohen M. The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women. Journal of Acquired Immune Deficiency Syndromes (1999). 39: 537-44. PMID 16044004  1
2005 Chu JH, Gange SJ, Anastos K, Minkoff H, Cejtin H, Bacon M, Levine A, Greenblatt RM. Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy. American Journal of Epidemiology. 161: 881-90. PMID 15840621 DOI: 10.1093/aje/kwi116  1
2005 Golub JE, Bur S, Cronin WA, Gange S, Sterling TR, Oden B, Baruch N, Comstock GW, Chaisson RE. Impact of empiric antibiotics and chest radiograph on delays in the diagnosis of tuberculosis International Journal of Tuberculosis and Lung Disease. 9: 392-397. PMID 15832463  1
2005 Schneider MF, Gange SJ, Margolick JB, Detels R, Chmiel JS, Rinaldo C, Armenian HK. Application of case-crossover and case-time-control study designs in analyses of time-varying predictors of T-cell homeostasis failure. Annals of Epidemiology. 15: 137-44. PMID 15652719 DOI: 10.1016/j.annepidem.2004.05.002  1
2005 Szczech LA, Hoover DR, Feldman JG, Cohen MH, Gange SJ, Palacio H, Rubin NR, Young MA, Cai X, Shi Q, Gao W, Anastos K. Renal markers that predict poor outcomes in HIV-infected women American Journal of Urology Review. 3: 185-188.  1
2004 Kensler TW, Egner PA, Wang JB, Zhu YR, Zhang BC, Lu PX, Chen JG, Qian GS, Kuang SY, Jackson PE, Gange SJ, Jacobson LP, Muñoz A, Groopman JD. Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas. Gastroenterology. 127: S310-8. PMID 15508099 DOI: 10.1053/j.gastro.2004.09.046  1
2004 Szczech LA, Hoover DR, Feldman JG, Cohen MH, Gange SJ, Goozé L, Rubin NR, Young MA, Cai X, Shi Q, Gao W, Anastos K. Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 39: 1199-206. PMID 15486845 DOI: 10.1086/424013  1
2004 Lau B, Gange SJ. Methods for the analysis of continuous biomarker assay data with increased sensitivity. Epidemiology (Cambridge, Mass.). 15: 724-32. PMID 15475722 DOI: 10.1097/01.ede.0000142154.86749.e4  1
2004 Philpott S, Burger H, Tarwater PM, Lu M, Gange SJ, Anastos K, Cohen M, Greenblatt RM, Kovacs A, Minkoff H, Young M, Miotti P, Dupuis M, Weiser B. CCR2 genotype and disease progression in a treated population of HIV type 1-infected women Clinical Infectious Diseases. 39: 861-865. PMID 15472820 DOI: 10.1086/423386  1
2004 Silverberg MJ, Gore ME, French AL, Gandhi M, Glesby MJ, Kovacs A, Wilson TE, Young MA, Gange SJ. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 39: 717-24. PMID 15356788 DOI: 10.1086/423181  1
2004 Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women Journal of the National Cancer Institute. 96: 1070-1076. PMID 15265968  1
2004 Barrón Y, Cole SR, Greenblatt RM, Cohen MH, Anastos K, DeHovitz JA, Delapenha R, Gange SJ. Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy Aids. 18: 1579-1584. PMID 15238776 DOI: 10.1097/01.aids.0000131359.37210.1f  1
2004 Wilson TE, Gore ME, Greenblatt R, Cohen M, Minkoff H, Silver S, Robison E, Levine A, Gange SJ. Changes in sexual behavior among HIV-infected women after initiation of HAART American Journal of Public Health. 94: 1141-1146. PMID 15226134  1
2004 Tun W, Gange SJ, Vlahov D, Strathdee SA, Celentano DD. Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 38: 1167-74. PMID 15095224 DOI: 10.1086/383033  1
2004 Szczech LA, Gange SJ, van der Horst C, Bartlett JA, Young M, Cohen MH, Anastos K, Klassen PS, Svetkey LP. Definition of proteinuria among women with HIV infection. Kidney International. 65: 1519. PMID 15086498 DOI: 10.1111/j.1523-1755.2004.555_2.x  1
2004 Sethi AK, Celentano DD, Gange SJ, Gallant JE, Vlahov D, Farzadegan H. High-risk behavior and potential transmission of drug-resistant HIV among injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 35: 503-10. PMID 15021315 DOI: 10.1097/00126334-200404150-00008  1
2004 Anastos K, Barrón Y, Cohen MH, Greenblatt RM, Minkoff H, Levine A, Young M, Gange SJ. The Prognostic Importance of Changes in CD4+ Cell Count and HIV-1 RNA Level in Women after Initiating Highly Active Antiretroviral Therapy Annals of Internal Medicine. 140: 256-264+I45. PMID 14970148  1
2004 Maurer T, Rodrigues LKE, Ameli N, Phanuphak N, Gange SJ, DeHovitz J, French AL, Glesby M, Jordan C, Khalsa A, Hessol NA. The Effect of Highly Active Antiretroviral Therapy on Dermatologic Disease in a Longitudinal Study of HIV Type 1-Infected Women Clinical Infectious Diseases. 38: 579-584. PMID 14765353 DOI: 10.1086/381264  1
2004 Greenspan D, Gange SJ, Phelan JA, Navazesh M, Alves MEAF, MacPhail LA, Mulligan R, Greenspan JS. Incidence of oral lesions in HIV-1-infected women: Reduction with HAART Journal of Dental Research. 83: 145-150. PMID 14742653  1
2003 Roebuck BD, Curphey TJ, Li Y, Baumgartner KJ, Bodreddigari S, Yan J, Gange SJ, Kensler TW, Sutter TR. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz. Carcinogenesis. 24: 1919-28. PMID 14555609 DOI: 10.1093/carcin/bgg173  1
2003 Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 37: 1112-8. PMID 14523777 DOI: 10.1086/378301  1
2003 Burke JK, Cook JA, Cohen MH, Wilson T, Anastos K, Young M, Palacio H, Richardson J, Gange S. Dissatisfaction with medical care among women with HIV: Dimensions and associated factors Aids Care - Psychological and Socio-Medical Aspects of Aids/Hiv. 15: 451-462. PMID 14509860 DOI: 10.1080/0954012031000134692  1
2003 Lau B, Gange SJ, Phair JP, Riddler SA, Detels R, Margolick JB. Rapid declines in total lymphocyte counts and hemoglobin concentration prior to AIDS among HIV-1-infected men. Aids (London, England). 17: 2035-44. PMID 14502006 DOI: 10.1097/01.aids.0000076314.76477.32  1
2003 Gray RH, Li X, Wawer MJ, Gange SJ, Serwadda D, Sewankambo NK, Moore R, Wabwire-Mangen F, Lutalo T, Quinn TC. Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda. Aids (London, England). 17: 1941-51. PMID 12960827 DOI: 10.1097/01.aids.0000076313.76477.fc  1
2003 Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, Duerr A, Massad LS, Celentano DD, Hall C, Fazzari M, Cu-Uvin S, Bacon M, Schuman P, Levine AM, ... ... Gange S, et al. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. Journal of the National Cancer Institute. 95: 1062-71. PMID 12865452  1
2003 Feldman JG, Gange SJ, Bacchetti P, Cohen M, Young M, Squires KE, Williams C, Goldwasser P, Anastos K. Serum albumin is a powerful predictor of survival among HIV-1-infected women. Journal of Acquired Immune Deficiency Syndromes (1999). 33: 66-73. PMID 12792357  1
2003 Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, Kovacs C, Gange SJ, Siliciano RF. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nature Medicine. 9: 727-8. PMID 12754504 DOI: 10.1038/nm880  1
2003 Philpott S, Weiser B, Tarwater P, Vermund SH, Kleeberger CA, Gange SJ, Anastos K, Cohen M, Greenblatt RM, Kovacs A, Minkoff H, Young MA, Miotti P, Dupuis M, Chen CH, et al. CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women. The Journal of Infectious Diseases. 187: 569-75. PMID 12599073 DOI: 10.1086/367995  1
2003 Gange SJ, Lau B, Phair J, Riddler SA, Detels R, Margolick JB. Rapid declines in total lymphocyte count and hemoglobin in HIV infection begin at CD4 lymphocyte counts that justify antiretroviral therapy. Aids (London, England). 17: 119-21. PMID 12478077 DOI: 10.1097/01.aids.0000042585.93174.11  1
2002 Kensler TW, Egner PA, Wang JB, Zhu YR, Zhang BC, Qian GS, Kuang SY, Gange SJ, Jacobson LP, Muñoz A, Groopman JD. Strategies for chemoprevention of liver cancer. European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 11: S58-64. PMID 12570336  1
2002 Gruskin L, Gange SJ, Celentano D, Schuman P, Moore JS, Zierler S, Vlahov D. Incidence of violence against HIV-infected and uninfected women: findings from the HIV Epidemiology Research (HER) study. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 79: 512-24. PMID 12468671 DOI: 10.1093/jurban/79.4.512  1
2002 Ruff CT, Ray SC, Kwon P, Zinn R, Pendleton A, Hutton N, Ashworth R, Gange S, Quinn TC, Siliciano RF, Persaud D. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure. Journal of Virology. 76: 9481-92. PMID 12186930 DOI: 10.1128/JVI.76.18.9481-9492.2002  1
2002 Kirstein LM, Greenblatt RM, Anastos K, Levine A, French AL, Minkoff H, Silver S, Gange SJ. Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV Study Journal of Acquired Immune Deficiency Syndromes. 29: 495-503. PMID 11981366  1
2002 French AL, Cohen MH, Gange SJ, Burger H, Gao W, Semba RD, Meyer WA, Robison E, Anastos K. Vitamin A deficiency and genital viral burden in women infected with HIV-1 Lancet. 359: 1210-1212. PMID 11955543 DOI: 10.1016/S0140-6736(02)08226-0  1
2002 Pierson TC, Kieffer TL, Ruff CT, Buck C, Gange SJ, Siliciano RF. Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication. Journal of Virology. 76: 4138-44. PMID 11907256 DOI: 10.1128/JVI.76.8.4138-4144.2002  1
2002 Gange SJ, Barrón Y, Greenblatt RM, Anastos K, Minkoff H, Young M, Kovacs A, Cohen M, Meyer WA, Muñoz A. Effectiveness of highly active antiretroviral therapy among HIV-1 infected women Journal of Epidemiology and Community Health. 56: 153-159. PMID 11812817 DOI: 10.1136/jech.56.2.153  1
2002 Szczech LA, Gange SJ, van der Horst C, Bartlett JA, Young M, Cohen MH, Anastos K, Klassen PS, Svetkey LP. Predictors of proteinuria and renal failure among women with HIV infection. Kidney International. 61: 195-202. PMID 11786101 DOI: 10.1046/j.1523-1755.2002.00094.x  1
2001 Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, Zhang QN, Qian GS, Kuang SY, Gange SJ, Jacobson LP, Helzlsouer KJ, Bailey GS, Groopman JD, Kensler TW. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer Proceedings of the National Academy of Sciences of the United States of America. 98: 14601-14606. PMID 11724948 DOI: 10.1073/pnas.251536898  1
2001 Nowicki MJ, Benning L, Bremer JW, Meyer WA, Hanson C, Brambilla D, Silver S, Kovacs A, Anastos K, Minkoff H, Young M, Greenblatt R, Palacio H, Levine A, Cohen M, ... ... Gange SJ, et al. Longitudinal variability of human immunodeficiency virus type 1 RNA viral load measurements by nucleic acid sequence-based amplification and nucliSens assays in a large multicenter study Journal of Clinical Microbiology. 39: 3760-3763. PMID 11574612 DOI: 10.1128/JCM.39.10.3760-3763.2001  1
2001 Gange SJ, Mellors JW, Lau B, Detels R, Phair JP, Muñoz A, Margolick JB. Longitudinal patterns of HIV type 1 RNA among individuals with late disease progression. Aids Research and Human Retroviruses. 17: 1223-9. PMID 11559421 DOI: 10.1089/088922201750461276  1
2001 Mirmirani P, Hessol NA, Maurer TA, Berger TG, Nguyen P, Khalsa A, Gurtman A, Micci S, Young M, Holman S, Gange SJ, Greenblatt RM. Prevalence and predictors of skin disease in the Women's Interagency HIV Study (WIHS) Journal of the American Academy of Dermatology. 44: 785-788. PMID 11312425 DOI: 10.1067/mjd.2001.112350  1
2001 Levine AM, Berhane K, Masri-Lavine L, Sanchez M, Young M, Augenbraun M, Cohen M, Anastos K, Newman M, Gange SJ, Watts H. Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's Interagency HIV Study. Journal of Acquired Immune Deficiency Syndromes (1999). 26: 28-35. PMID 11176266  1
2000 Ahdieh L, Gange SJ, Greenblatt R, Minkoff H, Anastos K, Young M, Nowicki M, Kovacs A, Cohen M, Muñoz A. Selection by indication of potent antiretroviral therapy use in a large cohort of women infected with human immunodeficiency virus American Journal of Epidemiology. 152: 923-933. PMID 11092434 DOI: 10.1093/aje/152.10.923  1
2000 DeHovitz JA, Kovacs A, Feldman JG, Anastos K, Young M, Cohen M, Gange SJ, Melnick S, Greenblatt RM. The relationship between virus load response to highly active antiretroviral therapy and change in CD4 cell counts: A report from the Women's Interagency HIV Study Journal of Infectious Diseases. 182: 1527-1530. PMID 11010840 DOI: 10.1086/315875  1
2000 Bing EG, Hays RD, Jacobson LP, Chen B, Gange SJ, Kass NE, Chmiel JS, Zucconi SL. Health-related quality of life among people with HIV disease: Results from the multicenter AIDS cohort study Quality of Life Research. 9: 55-63. PMID 10981206 DOI: 10.1023/A:1008919227665  1
2000 Anastos K, Gange SJ, Lau B, Weiser B, Detels R, Giorgi JV, Margolick JB, Cohen M, Phair J, Melnick S, Rinaldo CR, Kovacs A, Levine A, Landesman S, Young M, et al. Association of race and gender with HIV-1 RNA levels and immunologic progression. Journal of Acquired Immune Deficiency Syndromes (1999). 24: 218-26. PMID 10969345  1
2000 Hessol NA, Anastos K, Levine AM, Ameli N, Cohen M, Young M, Augenbraun M, Miotti P, Gange SJ. Factors associated with incident self-reported AIDS among women enrolled in the women's interagency HIV study (WIHS) Aids Research and Human Retroviruses. 16: 1105-1111. PMID 10954885 DOI: 10.1089/088922200414947  1
2000 Maas JJJ, Gange SJ, Schuitemaker H, Coutinho RA, Van Leeuwen R, Margolick JB. Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study Aids. 14: 1155-1161. PMID 10894279 DOI: 10.1097/00002030-200006160-00012  1
2000 Kensler TW, Dolan PM, Gange SJ, Lee JK, Wang Q, Posner GH. Conceptually new deltanoids (vitamin D analogs) inhibit multistage skin tumorigenesis. Carcinogenesis. 21: 1341-5. PMID 10874012  1
2000 Feldman JG, Burns DN, Gange SJ, Bacchetti P, Cohen M, Anastos K, Nowicki M, Delapena R, Miotti P. Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV Study Aids. 14: 863-870. PMID 10839595 DOI: 10.1097/00002030-200005050-00013  1
2000 Munoz A, Gange SJ, Jacobson LP. Distinguishing efficacy, individual effectiveness and population effectiveness of therapies Aids. 14: 754-756. PMID 10807204 DOI: 10.1097/00002030-200004140-00020  1
2000 Wiley DJ, Visscher BR, Grosser S, Hoover DR, Day R, Gange S, Chmiel JS, Mitsuyasu R, Detels R. Evidence that anoreceptive intercourse with ejaculate exposure is associated with rapid CD4 cell loss. Aids (London, England). 14: 707-15. PMID 10807194 DOI: 10.1097/00002030-200004140-00010  1
2000 Hennessey KA, Giorgi JV, Kaplan AH, Visscher BR, Gange S, Margolick JB, Riddler S, Phair J, Detels R. AIDS onset at high CD4+ cell levels is associated with high HIV load. Aids Research and Human Retroviruses. 16: 103-7. PMID 10659049 DOI: 10.1089/088922200309449  1
1999 Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H, Gupta P, Rinaldo CR, Learn GH, He X, Huang XL, Mullins JI. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection Journal of Virology. 73: 10489-10502. PMID 10559367  1
1999 Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, Quinn TC, Chaisson RE, Rosenberg E, Walker B, Gange S, et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nature Medicine. 5: 512-7. PMID 10229227 DOI: 10.1038/8394  1
1998 Rinaldo C.R. J, Gupta P, Huang XL, Fan Z, Mullins JI, Gange S, Farzadegan H, Shankarappa R, Munoz A, Margolick JB. Anti-HIV type 1 memory cytotoxic T lymphocyte responses associated with changes in CD4+ T cell numbers in progression of HIV type 1 infection Aids Research and Human Retroviruses. 14: 1423-1433. PMID 9824320  1
1998 Muñoz A, Gange SJ. Methodological issues for biomarkers and intermediate outcomes in cohort studies Epidemiologic Reviews. 20: 29-42. PMID 9762507  1
1998 Gange SJ, Muñoz A, Chmiel JS, Donnenberg AD, Kirstein LM, Detels R, Margolick JB. Identification of inflections in T-cell counts among HIV-1-infected individuals and relationship with progression to clinical AIDS Proceedings of the National Academy of Sciences of the United States of America. 95: 10848-10853. PMID 9724793 DOI: 10.1073/pnas.95.18.10848  1
1997 Jacobson DL, Gange SJ, Rose NR, Graham NMH. Epidemiology and estimated population burden of selected autoimmune diseases in the United States Clinical Immunology and Immunopathology. 84: 223-243. PMID 9281381 DOI: 10.1006/clin.1997.4412  1
1997 Kensler TW, Gange SJ, Egner PA, Dolan PM, Muñoz A, Groopman JD, Rogers AE, Roebuck BD. Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 6: 603-10. PMID 9264273  1
1997 Yong FH, Taylor JM, Bryant JL, Chmiel JS, Gange SJ, Hoover D. Dependence of the hazard of AIDS on markers. Aids (London, England). 11: 217-28. PMID 9030370 DOI: 10.1097/00002030-199702000-00013  1
1997 Gange SJ, Marsh M. Association of aspects of vision and quality-of-life in patients with subfoveal choroidal neovascularization Investigative Ophthalmology and Visual Science. 38.  1
1996 Gange SJ, Jacobson LP, Muñoz A. Parametric models to assess tracking of categorical high-risk sexual behaviour for HIV infection Statistics in Medicine. 15: 2323-2336. PMID 8931204 DOI: 10.1002/(SICI)1097-0258(19961115)15:21<2323::AID-SIM451>3.0.CO;2-P  1
1996 Townsley-Fuchs J, Kam L, Fairhurst R, Gange SJ, Goodglick L, Giorgi JV, Sidell N, Detels R, Braun J. Human immunodeficiency virus-1 (HIV-1) gp120 superantigen-binding serum antibodies: A host factor in homosexual HIV-1 transmission Journal of Clinical Investigation. 98: 1794-1801. PMID 8878430  1
1996 Kee C, Gabelt BT, Gange SJ, Kaufman PL. Serum effects on aqueous outflow during anterior chamber perfusion in monkeys. Investigative Ophthalmology & Visual Science. 37: 1840-8. PMID 8759352  1
1996 Pirsch JD, Ploeg RJ, Gange S, D'Alessandro AM, Knechtle SJ, Sollinger HW, Kalayoglu M, Belzer FO. Determinants of graft survival after renal transplantation. Transplantation. 61: 1581-6. PMID 8669101 DOI: 10.1097/00007890-199606150-00006  1
1996 Crawford KS, Gange SJ, Gabelt BT, Heideman W, Robinson JC, Hubbard WC, Kaufman PL. Indomethacin and epinephrine effects on outflow facility and cyclic adenosine monophosphate formation in monkeys. Investigative Ophthalmology & Visual Science. 37: 1348-59. PMID 8641838  1
1996 Croft MA, Oyen MJ, Gange SJ, Fisher MR, Kaufman PL. Aging effects on accommodation and outflow facility responses to pilocarpine in humans. Archives of Ophthalmology (Chicago, Ill. : 1960). 114: 586-92. PMID 8619770  1
1996 Gange SJ, DeMets DL. Sequential monitoring of clinical trials with correlated responses Biometrika. 83: 157-167.  1
1996 Gange SJ, Muñoz A, Sáez M, Alonso J. Use of the beta - binomial distribution to model the effect of policy changes on appropriateness of hospital stays Journal of the Royal Statistical Society. Series C: Applied Statistics. 45: 371-382.  1
1996 Pendergast JF, Gange SJ, Newton MA, Lindstrom MJ, Palta M, Fisher MR. A survey off methods for analyzing clustered binary response data International Statistical Review. 64: 89-118.  1
1995 Gange SJ, Linton KLP, Scott AJ, DeMets DL, Klein R. A comparison of methods for correlated ordinal measures with ophthalmic applications Statistics in Medicine. 14: 1961-1974. PMID 8677397  1
1995 Ménage MJ, Croft MA, Gange SJ, Kaufman PL. epsilon-Aminocaproic acid does not inhibit outflow resistance washout in monkeys. Investigative Ophthalmology & Visual Science. 36: 1745-9. PMID 7635651  1
1995 Egner PA, Gange SJ, Dolan PM, Groopman JD, Muñoz A, Kensler TW. Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz Carcinogenesis. 16: 1769-1773. PMID 7634402 DOI: 10.1093/carcin/16.8.1769  1
1995 Gabelt BT, Robinson JC, Gange SJ, Kaufman PL. Superior cervical ganglionectomy in monkeys: aqueous humor dynamics and their responses to drugs. Experimental Eye Research. 60: 575-84. PMID 7615023 DOI: 10.1016/S0014-4835(05)80072-7  1
1995 Gange SJ. Generating multivariate categorical variates using the iterative proportional fitting algorithm American Statistician. 49: 134-138. DOI: 10.1080/00031305.1995.10476130  1
1994 Ploeg RJ, D'Alessandro AM, Groshek M, Gange SJ, Knechtle SJ, Stegall MD, Eckhoff DE, Pirsch JD, Sollinger HW, Belzer FO. Clinical experience with human anodal trypsinogen (HAT) for detection of pancreatic allograft rejection Transplant International : Official Journal of the European Society For Organ Transplantation. 7. PMID 11271272  1
1994 Ploeg RJ, D'Alessandro AM, Groshek M, Gange SJ, Knechtle SJ, Stegall MD, Eckhoff DE, Pirsch JD, Sollinger HW, Belzer FO. Efficacy of human anodal trypsinogen for detection of rejection in clinical pancreas transplantation Transplantation Proceedings. 26: 531-533. PMID 7513455  1
1993 Wallow IHL, Bindley CD, Reboussin DM, Gange SJ, Fisher MR. Systemic hypertension produces pericyte changes in retinal capillaries Investigative Ophthalmology and Visual Science. 34: 420-430. PMID 8440597  1
1993 Wallow IHL, Sramek SJ, Bindley CD, Darjatmoko SR, Gange SJ. Ocular renin angiotensin: EM immunocytochemical localization of prorenin Current Eye Research. 12: 945-950. PMID 8293670 DOI: 10.3109/02713689309020401  1
Show low-probability matches.